Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.9%

6 terminated/withdrawn out of 102 trials

Success Rate

92.2%

+5.7% vs industry average

Late-Stage Pipeline

5%

5 trials in Phase 3/4

Results Transparency

35%

25 of 71 completed trials have results

Key Signals

8 recruiting25 with results

Enrollment Performance

Analytics

N/A
59(63.4%)
Phase 2
17(18.3%)
Phase 1
11(11.8%)
Phase 4
3(3.2%)
Phase 3
2(2.2%)
Early Phase 1
1(1.1%)
93Total
N/A(59)
Phase 2(17)
Phase 1(11)
Phase 4(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (102)

Showing 20 of 102 trials
NCT07497399Phase 2Recruiting

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Role: collaborator

NCT05715268Not ApplicableActive Not Recruiting

Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study

Role: collaborator

NCT06390930Not ApplicableRecruiting

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Role: collaborator

NCT04768777Not ApplicableNot Yet Recruiting

Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis

Role: collaborator

NCT03490240Not ApplicableActive Not Recruiting

Project BIPAMS: Behavioral Intervention for Physical Activity in Multiple Sclerosis

Role: collaborator

NCT06919900Not ApplicableRecruiting

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

Role: collaborator

NCT03500328Not ApplicableActive Not Recruiting

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

Role: collaborator

NCT04782466Not ApplicableActive Not Recruiting

ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program

Role: collaborator

NCT04695080Phase 2Active Not Recruiting

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Role: collaborator

NCT06197685Not ApplicableRecruiting

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

Role: collaborator

NCT06901687Phase 2Recruiting

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

Role: collaborator

NCT06495138Not ApplicableRecruiting

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

Role: collaborator

NCT05543915Not ApplicableCompleted

Cognitive Markers in Prodromal MS

Role: collaborator

NCT05878873Not ApplicableCompleted

The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis

Role: collaborator

NCT03896217Phase 2Completed

Simvastatin in Secondary Progressive Multiple Sclerosis

Role: collaborator

NCT06170970Phase 2Recruiting

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Role: collaborator

NCT06870968Not ApplicableNot Yet Recruiting

FIT-ATOMIC Exercise Feasibility Trial

Role: collaborator

NCT02740361Not ApplicableCompleted

Online Program to Reduce Depression in MS

Role: collaborator

NCT02433028Recruiting

Swiss Multiple Sclerosis Cohort-Study

Role: collaborator

NCT02914964Not ApplicableCompleted

Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study

Role: collaborator